Reducing the Incidence of Colorectal Cancer
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The prevalence of colorectal cancer could be reduced by 95% with proper screening in every patient at recommended age intervals. That’s according to Dr. Steven Stryker, professor of clinical surgical oncology at Northwestern University’s Feinberg School of Medicine. Yet colorectal cancer remains the second most common cancer in America. Dr. Stryker joins host Dr. Lauren Streicher to explain how physicians can encourage patient compliance with current screening modalities. What circumstances favor virtual screening? Are there other common procedures that can facilitate the diagnosis of colorectal cancer?
Overview
The prevalence of colorectal cancer could be reduced by 95% with proper screening in every patient at recommended age intervals. That’s according to Dr. Steven Stryker, professor of clinical surgical oncology at Northwestern University’s Feinberg School of Medicine. Yet colorectal cancer remains the second most common cancer in America. Dr. Stryker joins host Dr. Lauren Streicher to explain how physicians can encourage patient compliance with current screening modalities. What circumstances favor virtual screening? Are there other common procedures that can facilitate the diagnosis of colorectal cancer?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?